Skip to main content

Rapport Therapeutics

Rapport Therapeutics Inc is an American clinical-stage biopharmaceutical enterprise headquartered in Boston, Massachusetts. The company specializes in the discovery and development of precision neuroscience therapeutics targeting receptor-associated proteins for the treatment of central nervous system (CNS) disorders, including epilepsy, chronic pain, and psychiatric conditions. Its proprietary discovery platform identifies novel drug targets with high anatomical precision. Principal revenue is currently earned through strategic pharmaceutical research partnerships, milestone payments, and capital financing arrangements. Rapport Therapeutics Inc is publicly listed on the Nasdaq Stock Market.

3 of the funds FundTelligence covers report a position in Rapport Therapeutics.

Legal name
RAPPORT THERAPEUTICS
Sector
Health Care
Country
United States
Funds holding it
3

Funds holding Rapport Therapeutics

Loading...